Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引：9

作者：

Serban, Dragos ^{[1
,2
]}

Costea, Daniel Ovidiu ^{[3
,4
]}

Zgura, Anca ^{[5
,6
]}

Tudosie, Mihail Silviu ^{[7
,8
]}

Dascalu, Ana Maria ^{[9
,10
]}

Gangura, Gabriel Andrei ^{[1
,11
]}

Smarandache, Catalin Gabriel ^{[1
,2
]}

Sabau, Alexandru Dan ^{[12
,13
]}

Tudor, Corneliu ^{[2
]}

Faur, Mihai ^{[12
,13
]}

Costea, Andreea Cristina ^{[14
]}

Stana, Daniela ^{[10
]}

Balasescu, Simona Andreea ^{[2
]}

Tribus, Laura Carina ^{[15
,16
]}

Tanasescu, Ciprian ^{[12
,13
]}

机构：

[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania

[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania

[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania

[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania

[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania

[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania

[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania

[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania

[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania

[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania

[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania

[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania

[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania

[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania

[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania

来源：

IN VIVO | 2022年 / 36卷 / 01期

关键词：

Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;

D O I：

10.21873/invivo.12674

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.

引用

页码：40 / 48

页数：9

共 50 条

[31] The maintenance effect of acupuncture on the side effects of breast cancer endocrine therapy A protocol for systematic review and meta analysis
Shi, Kejin
Tang, Ying
He, Fengyi
Xiao, Xiao
Zhang, Jiayuan
Jin, Yuxia
Wang, Yunxia
Zhang, Qi
MEDICINE, 2020, 99 (24) : E20567
[32] Bisphosphonate use in women with breast cancer on aromatase inhibitor therapy
McGowan, A.
van der Kamp, S.
McKenna, M. J.
IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S463 - S463
[33] Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study of the Effects of Vaginal Testosterone Therapy
Dahir, Melissa
Travers-Gustafson, Dianne
SEXUAL MEDICINE, 2014, 2 (01): : 8 - 15
[34] Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review
Georgalas, Ilias
Paraskevopoulos, Theodore
Koutsandrea, Chryssanthi
Kardara, Evgenia
Malamos, Panagiotis
Ladas, Dimitrios
Papaconstantinou, Dimitris
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[35] Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings
Ingle, JN
CLINICAL CANCER RESEARCH, 2005, 11 (02) : 900S - 905S
[36] Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
Stoicescu, Elena Andreea
Burcea, Marian
Iancu, Raluca Claudia
Zivari, Mirela
Popa Cherecheanu, Alina
Bujor, Inna Adriana
Rastoaca, Cristina
Iancu, George
PROCESSES, 2021, 9 (07)
[37] Persistence to aromatase inhibitor therapy among older women with breast cancer
Huiart, L.
Bouhnik, A. D.
Rey, D.
Rousseau, F.
Retornaz, F.
Meresse, M.
Bendiane, M. K.
Viens, P.
Giorgi, R.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S342 - S342
[38] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Gnant, Michael
Fitzal, Florian
Rinnerthaler, Gabriel
Steger, Guenther G.
Greil-Ressler, Sigrun
Balic, Marija
Heck, Dietmar
Jakesz, Raimund
Thaler, Josef
Egle, Daniel
Manfreda, Diether
Bjelic-Radisic, Vesna
Wieder, Ursula
Singer, Christian F.
Melbinger-Zeinitzer, Elisabeth
Haslbauer, Ferdinand
Sevelda, Paul
Trapl, Harald
Wette, Viktor
Wimmer, Kerstin
Gampenrieder, Simon P.
Bartsch, Rupert
Kacerovsky-Strobl, Stephanie
Suppan, Christoph
Brunner, Christine
Deutschmann, Christine
Soelkner, Lidija
Fesl, Christian
Greil, Richard
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
[39] Aromatase inhibitor therapy and hair loss among breast cancer survivors
Gallicchio, Lisa
Calhoun, Carla
Helzlsouer, Kathy J.
BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 435 - 443
[40] The Paclitaxel and Toremifene Therapy for Aromatase Inhibitor Resistant Metastatic Breast Cancer
Sakurai, Kenichi
Fujisaki, Shigeru
Adachi, Keita
Kubota, Hitomi
Suzuki, Shuhei
Tomita, Ryouichi
Hirano, Tomohiro
Suzuki, Yuna
CANCER SCIENCE, 2022, 113 : 1024 - 1024

← 1 2 3 4 5 →